Skip to search formSkip to main contentSkip to account menu

Atracurium

Known as: Atracurium [Chemical/Ingredient], Isoquinolinium, 2,2'-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl))-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl- 
A non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of… 
National Institutes of Health

Related topics

Related topics

16 relations

Narrower (4)

Atracurium BesylateBW-33ACisatracuriumTracrium
Atracurium leukotriene release:MCnc:Pt:WBC:QnDrug AllergyIn BloodNeuromuscular Nondepolarizing Blockade [PE]

Broader (2)

Neuromuscular Nondepolarizing AgentsNicotinic Antagonists

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Increased sensitivity to rocuronium and atracurium in mitochondrial myopathy
PurposeTo describe the prolonged effect of the intermediate-acting, non-depolarising neuromuscular blocking agents rocuronium and… 
Highly Cited
1993
Highly Cited
1993
Recovery following outpatient anesthesia: use of enflurane versus propofol.
Highly Cited
1988
Highly Cited
1988
Residual curarisation: a comparative study of atracurium and pancuronium
Sixty patients (17–78 years old, ASA group I–II) were included in the study, which was triple–blind, randomised, stratified and… 
1986
1986
Atracurium or vecuronium for rapid sequence endotracheal intubation.
Conditions excellentes d'intubation apres l'injection bolus de 1,5 mg/kg d'atracurium ou 0,25 mg/kg de vecuronium 
1986
1986
Atracurium infusions in patients with renal failure on an ITU
An infusion of atracurium was used (after an initial bolus dose) in five patients with renal and respiratory failure, who were… 
1985
1985
The Cerebral Effects of Pancuronium and Atracurium in Halothane‐anesthetized Dogs
Pancuronium decreases the minimal alveolar anesthetic concentration (MAC) of halothane in humans, while atracurium has a… 
Highly Cited
1983
Highly Cited
1983
Pharmacokinetics, pharmacodynamics and dose-response relationships of atracurium administered i.v.
: A complete pharmacokinetic and pharmacodynamic model for the novel non-depolarizing neuromuscular blocking agent atracurium is… 
Highly Cited
1983
Highly Cited
1983
Intubation conditions after atracurium and suxamethonium.
Conditions for endotracheal intubation provided by different dose regimens of atracurium 0.4 mg kg-1 and 0.5 mg kg-1 were studied… 
Highly Cited
1983
Highly Cited
1983
Muscular relaxation with atracurium, vecuronium and duador under balanced anaesthesia.
The neuromuscular effects of three new nondepolarizing neuromuscular blocking drugs, atracurium, vecuronium and Duador, were… 
Highly Cited
1982
Highly Cited
1982
Neuromuscular Effects of Atracurium in Man
The neuromuscular effects of atracurium were studied in 25 A. S. A. class I or II patients anesthetized by a N2O-O2narcotic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)